Physician profile
William Waller
NPI 1053592840
$18,663.98
in general payments reported to CMS, 2019-2025
47 companies · $3,407 in 2025
The $3,407 reported for 2025 was more than what 86% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,960 · 2020: $1,042 · 2021: $1,918 · 2022: $3,876 · 2023: $3,312 · 2024: $3,151 · 2025: $3,407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,500 · Education: $369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,500.15 |
| Education | $368.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,654.60 | 2019-2025 | Botox, Rinvoq, Skyrizi |
| Novartis Pharmaceuticals Corporation | $2,256.09 | 2019-2025 | |
| Merz North America, INC. | $1,338.17 | 2019-2023 | Xeomin |
| Genzyme Corporation | $1,155.16 | 2019-2025 | |
| Janssen Biotech, INC. | $1,090.11 | 2019-2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $943.41 | 2019-2025 | Ilumya, Absorica Ld, Winlevi |
| Regeneron Healthcare Solutions, INC. | $937.02 | 2019-2025 | Dupixent, Libtayo |
| Incyte Corporation | $652.60 | 2022-2025 | Opzelura |
| Leo Pharma INC. | $633.36 | 2019-2025 | Adbry, Anzupgo, Spevigo |
| Ucb, INC. | $578.68 | 2019-2025 | Bimzelx |
| E.R. Squibb & Sons, L.L.C. | $574.72 | 2022-2025 | Sotyktu |
| Lilly USA, LLC | $545.00 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Allergan, INC. | $523.91 | 2019-2022 | |
| Amgen INC. | $495.35 | 2019-2025 | Otezla, Otezla |
| Galderma Laboratories, L.P. | $431.69 | 2019-2025 | Nemluvio, Dysport, Epsolay |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Waller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.